Isolated ocular disease is associated with decreased mucolipin-1 channel conductance

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 3134-3142

  Goldin, Ehud ^a   Caruso, Rafael C ^b   Benko, William ^c   Kaneski, Christine R ^c   Stahl, Stephanie ^c   Schiffmann, Raphael ^c,d  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; DNA; GASTRIN; ION CHANNEL; LIPOSOME; MUCOLIPIN 1 CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; UNCLASSIFIED DRUG; GUANINE; MCOLN1 PROTEIN, HUMAN; THYMINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M;

ACHLORHYDRIA; ADOLESCENT; ARTICLE; AUTOFLUORESCENCE; CASE REPORT; CELL MEMBRANE CONDUCTANCE; DNA SEQUENCE; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; GASTRIN BLOOD LEVEL; GENE MUTATION; HETEROZYGOTE; HUMAN; IN VITRO STUDY; MALE; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; MUTATIONAL ANALYSIS; NEUROOPHTHALMOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA BIPOLAR GANGLION CELL; RETINA DYSTROPHY; RETINA ROD; SCREENING TEST; STOMACH PH; BLOOD; GENE DELETION; GENETICS; METABOLISM; MUTATION; PATHOPHYSIOLOGY; RETINA DISEASE;

ACHLORHYDRIA; ADOLESCENT; ELECTRORETINOGRAPHY; GASTRINS; GENE DELETION; GUANINE; HETEROZYGOTE; HUMANS; MALE; MUCOLIPIDOSES; MUTATION; RETINAL BIPOLAR CELLS; RETINAL DISEASES; RODS (RETINA); THYMINE; TRPM CATION CHANNELS;

EID: 48249110279     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1649     Document Type: Article

References (19)

1. Puech B, Kostrubiec B, Hache JC, Francois P. Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France (in French). J Fr Ophtalmol. 1991;14:153-164.
2. Berman ER, Livni N, Shapira E, Merin S, Levij IS. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr. 1974;84:519-526.
3. Altarescu G, Sun M, Moore DF, et al. The neurogenetics of mucolipidosis type IV. Neurology. 2002;59:306-313. (Pubitemid 34857920)
4. Smith JA, Chan CC, Goldin E, Schiffmann R. Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV. Ophthalmology. 2002;109:588-594. (Pubitemid 34184931)
5. Dobrovolny R, Liskova P, Ledvinova J, et al. Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation. Am J Ophthalmol. 2007;143:663-671.
6. Casteels I, Taylor DS, Lake BD, Spalton DJ, Bach G. Mucolipidosis type IV. Presentation of a mild variant. Ophthalmic Paediatr Genet. 1992;13:205-210.
7. Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am J Hum Genet. 2000;67:1110-1120. (Pubitemid 30816316)
8. Bargal R, Avidan N, Ben-Asher E, et al. Identification of the gene causing mucolipidosis type IV. Nat Genet. 2000;26:118-123. (Pubitemid 30692871)
9. Sun M, Goldin E, Stahl S, et al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet. 2000;9:2471-2478. (Pubitemid 30814634)
10. Raychowdhury MK, Gonzalez-Perrett S, Montalbetti N, et al. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum Mol Genet. 2004;13:617-627. (Pubitemid 38379851)
11. Goldin E, Cooney A, Kaneski CR, Brady RO, Schiffmann R. Mucolipidosis IV consists of one complementation group. Proc Natl Acad Sci USA. 1999;96:8562-8566. (Pubitemid 29354831)
12. Schiffmann R, Dwyer NK, Lubensky IA, et al. Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci USA. 1998;95:1207-1212. (Pubitemid 28124937)
13. Vergarajauregui S, Oberdick R, Kiselyov K, Puertollano R. Mucolipin-1 channel activity is regulated by protein kinase A mediated phosphorylation. Biochem J. 2008;410:417-427. (Pubitemid 351346200)
14. LaPlante JM, Ye CP, Quinn SJ, et al. Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun. 2004;322:1384-1391. (Pubitemid 39164668)
15. Cantiello HF, Montalbetti N, Goldmann WH, et al. Cation channel activity of mucolipin-1: the effect of calcium. Pflugers Arch. 2005;451:304-312. (Pubitemid 41424934)
16. Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, et al. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem. 2006;281:7294-7301. (Pubitemid 43847497)
17. Kiselyov K, Soyombo A, Muallem S. TRPpathies. J Physiol. 2007; 578:641-653.
18. Zhang F, Li PL. Reconstitution and characterization of a nicotinic acid adenine dinucleotide phosphate (NAADP)-sensitive Ca2+ release channel from liver lysosomes of rats. J Biol Chem. 2007;282:25259-25269. (Pubitemid 47372834)
19. Schaheen L, Patton G, Fares H. Suppression of the cup-5 mucolipidosis type IV-related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans. Development. 2006;133:3939-3948. (Pubitemid 44650971)